NCT06478485 Laminoplasty for Multilevel Cervical Spondylotic Myelopathy Guided by Modified K-line and Modified SC-line in MRI
| NCT ID | NCT06478485 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Affiliated 2 Hospital of Nantong University |
| Condition | Modified K-line and Modified SC-line in MRI |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2020-01-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study intended to investigate the combined Impact of mK-line and mSC-line on the selection of the surgical approach and whether could be used to predict sufficient decompression of cervical spinal cord and clinical outcome in patients after LAMP.
Eligibility Criteria
Inclusion Criteria: (1) Diagnosis of MCSM confirmed by two spine surgeons with MRI examination and clinic signs; (2) More than 2 level lesions and/or spinal stenosis in MRI, underwent LAMP surgery; (3) Available for both preoperative and follow-up imaging data and clinical data, including sex, age, clinical symptoms, Japanese Orthopedic Association (JOA) score, Visual Analog Scale (VAS) score, Neck Disability Index(NDI) score and MRI data. Exclusion Criteria: (1) Previous cervical spine surgery; (2) Diagnosis of tumor, central cord syndrome, infection or other acute traumatic injuries; (3) Diagnosed neurological disorders Parkinson's disease, polio, multiple sclerosis, or other central and peripheral nervous system diseases).
Contact & Investigator
Zhiming Cui, Professor
PRINCIPAL INVESTIGATOR
Second Affiliated Hospital of Nantong University
Frequently Asked Questions
Who can join the NCT06478485 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Modified K-line and Modified SC-line in MRI. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06478485 currently recruiting?
Yes, NCT06478485 is actively recruiting participants. Contact the research team at wcsspine@ntu.edu.cn for enrollment information.
Where is the NCT06478485 trial being conducted?
This trial is being conducted at Nantong, China.
Who is sponsoring the NCT06478485 clinical trial?
NCT06478485 is sponsored by Affiliated 2 Hospital of Nantong University. The principal investigator is Zhiming Cui, Professor at Second Affiliated Hospital of Nantong University. The trial plans to enroll 300 participants.